Cargando…
Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
Necrolytic migratory erythema (NME) is usually associated with paraneoplastic syndrome caused by functional pancreatic neuroendocrine tumor (PNET). Accurate diagnosis and effective treatment of NET-related NME is challenging due to its rarity and lack of typical clinical symptoms and specific pathol...
Autores principales: | Liu, Zhongan, Hu, Feng, Guo, Shuang, Zhang, Peng, Li, Guiling, Qin, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685408/ https://www.ncbi.nlm.nih.gov/pubmed/38035045 http://dx.doi.org/10.1515/biol-2022-0672 |
Ejemplares similares
-
Necrolytic Migratory Erythema as the First Manifestation of Glucagonoma
por: Afsharfard, Abolfazl, et al.
Publicado: (2012) -
Case of delayed diagnosis of necrolytic migratory erythema
por: Abdelli, Wissal, et al.
Publicado: (2021) -
Acute onset of necrolytic migratory erythema mimicking an erythema multiforme
por: Juśko, Natalia, et al.
Publicado: (2020) -
Necrolytic Migratory Erythema Associated with Glucagonoma: A Report of 2 Cases
por: Teixeira, Renata Câmara, et al.
Publicado: (2008) -
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor
por: Wu, Sheng-li, et al.
Publicado: (2014)